Cargando…

Terbium-149 for targeted alpha therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Borgna, Francesca, Favaretto, Chiara, Grundler, Pascal, Johnston, Karl, Köster, Ulli, Müller, Cristina, Talip, Zeynep, van der Meulen, Nick
Publicado:	2021
Materias:	Detectors and Experimental Techniques
Acceso en línea:	http://cds.cern.ch/record/2748660

Ejemplares similares

Terbium-149 for targeted alpha therapy
por: Grundler, Pascal, et al.
Publicado: (2023)

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
por: Müller, Cristina, et al.
Publicado: (2016)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging
por: Favaretto, C., et al.
Publicado: (2021)

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021)

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Alpha-PET for Prostate Cancer: Preclinical investigation using (149)Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

(161)Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of (161)Tb into the Clinic
por: Favaretto, Chiara, et al.
Publicado: (2023)

Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
por: Borgna, Francesca, et al.
Publicado: (2021)

Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161
por: Juget, Frédéric, et al.
Publicado: (2022)

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with $^152$Tb-DOTATOC
por: Baum, Richard P, et al.
Publicado: (2017)

Targeted cancer therapy: the potential role of terbium-149
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Developments toward the Implementation of (44)Sc Production at a Medical Cyclotron
por: van der Meulen, Nicholas P., et al.
Publicado: (2020)

A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with (68)Ga, (44)Sc, (177)Lu and (161)Tb
por: Talip, Zeynep, et al.
Publicado: (2020)

Off-line separation of reactor produced $^{169}$Er for medical applications
por: Formento Cavaier, Roberto, et al.
Publicado: (2017)

Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy
por: Gracheva, Nadezda, et al.
Publicado: (2019)

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
por: Müller, Cristina, et al.
Publicado: (2018)

Activity Measurement of (44)Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics
por: Juget, Frederic, et al.
Publicado: (2023)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Koester, Ulli, et al.
Publicado: (2018)

149th SPSC Meeting
Publicado: (2023)

149th LHCC Meeting
Publicado: (2022)

Minutes of the 149th Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Köster, Ulli
Publicado: (2017)

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Confirmation of the proposals T 148 - T 149 $K^{+}p$ and $K^{+}d$ experiments at 16 GeV/c
por: Müller, F
Publicado: (1968)

Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90
por: Hemmingsson, Jens, et al.
Publicado: (2022)

Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN
por: Webster, Ben, et al.
Publicado: (2019)

Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN
por: Webster, Ben, et al.
Publicado: (2019)

Temperature effects on alpha radioactivity of $^{223}$Ra
por: Huber, Gerhard, et al.
Publicado: (2006)

Ytterbium-175 half-life determination
por: Durán, M Teresa, et al.
Publicado: (2021)

Agenda of the 149th Meeting of the SPSC, 10 and 11 May 2023
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2023)

Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations
por: Talip, Zeynep, et al.
Publicado: (2021)

Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations
por: Talip, Zeynep, et al.
Publicado: (2021)

Minutes of the 149th Meeting of the SPSC, Wednesday 10 and Thursday 11 May 2023
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2023)

Agenda of the 149th LHCC Meeting - Wednesday 9 and Thursday 10 March, 2022
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

Fast-timing studies from the beta-decay of n-rich Cl isotopes
por: Fraile-Prieto, L M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_crvd9b6v9qlf05qgcs58uoc12l